Abstract
Pockets of susceptibility resulting from spatial or social heterogeneity in vaccine coverage can drive measles outbreaks, as cases imported into such pockets are likely to cause further transmission and lead to large transmission clusters. Characterising the dynamics of transmission is essential for identifying which individuals and regions might be most at risk.
As data from detailed contact tracing investigations are not available in many settings, we combined age, location, genotype, and onset date of cases in order to probabilistically reconstruct the importation status and transmission clusters within a newly developed R package called o2geosocial.
We compared our inferred cluster size distributions to 737 transmission clusters identified through detailed contact-tracing in the United States between 2001 and 2016. We were able to reconstruct the importation status of the cases and found good agreement between the inferred and reference clusters. The results were improved when the contact-tracing investigations were used to set the importation status before running the model.
Spatial heterogeneity in vaccine coverage is difficult to measure directly. Our approach was able to highlight areas with potential for local transmission using a minimal number of variables and could be applied to assess the intensity of ongoing transmission in a region.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AR was supported by the Medical Research Council (MR/N013638/1). SF was supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (210758/Z/18/Z). AJK was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (206250/Z/17/Z).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The surveillance data used to validate this algorithm was provided by the CDC, the combinations of variables in the dataset may contain sensitive personally identifiable health information which are subject to the Privacy Act and cannot be shared publicly. The package we developed is publicly available on Github (https://github.com/alxsrobert/o2geosocial), along with the code used to analyse the data and generate the figures (https://github.com/alxsrobert/datapaperMO). A toy dataset was attached to the o2geosocial package (in o2geosocial/data). The script analysis_generated_data.R in the datapaperMO repository generates toy datasets with different parameters (distance kernel, number of cases, reproduction numbers…) and can be used to re-run the model and test its performance.
